TL;DR: Connected medical devices expand patient care but also widen attack surfaces, and Fortune Business Insights projects the global IoMT market will reach almost $188 billion by 2028 while 70.6 million Americans are expected to use remote patient monitoring by 2025, according to DigiCert’s source article. Digital trust is now a device identity and lifecycle problem, not just a network security problem.
At a glance
What this is: This is an analysis of how connected medical devices and IoMT security depend on device identity, certificate-based trust, and lifecycle governance rather than perimeter controls alone.
Why it matters: IAM, security, and device teams need to treat IoMT as an identity and lifecycle problem because compromised or mismanaged devices can affect patient data, clinical workflows, and safety-critical operations.
Context
Connected medical devices create a governance gap when teams assume network segmentation alone can secure devices that authenticate, transmit data, and integrate with clinical systems. In IoMT environments, trust has to follow the device across manufacturing, deployment, operation, and update cycles.
DigiCert frames digital trust as the mechanism that lets device identity, certificate issuance, and encrypted communications remain reliable as connected medical devices scale. That matters because hospitals, manufacturers, and regulators are now dealing with device estates whose security posture changes over time, not at a single onboarding event.
Key questions
Q: How should healthcare teams govern connected medical device identity?
A: Treat connected medical devices as managed identities with their own lifecycle. Each device should have a unique trust record, controlled authentication method, and revocation path. Governance must cover manufacturing, deployment, backend access, patching, and retirement, because the risk does not end when the device leaves the factory.
Q: Why do connected medical devices require stronger risk assessment than ordinary IT systems?
A: Because a weakness in a connected medical device can affect care delivery, not just data confidentiality. Risk assessment must consider exploitability, clinical impact, and the likelihood that a compromise could interfere with essential device performance. That is a different threshold from standard enterprise patching, where the primary concern is usually business disruption rather than patient harm.
Q: What breaks when medical device certificates are not centrally governed?
A: When certificate governance is fragmented, devices can outlive their trust state, renewal windows are missed, and revocation becomes unreliable. That creates hidden exposure because a device may still appear operational while its identity or communication assurance is no longer current. In IoMT environments, that gap can affect both clinical availability and integrity of care.
Q: How do encrypted communications change IoMT security outcomes?
A: Encrypted communications protect both the confidentiality and the integrity of device traffic, which matters when the data is clinical telemetry, remote monitoring output, or commands that influence treatment. Without encryption and integrity checks, attackers can read, alter, or redirect sensitive device communications. For IoMT, secure transport is part of device trust, not a separate control layer.
Technical breakdown
How device identity underpins IoMT trust
Connected medical devices need cryptographic identity so other systems can verify that a pump, monitor, or sensor is genuine before it is allowed to communicate. Digital certificates support that trust relationship by binding a device to an identity that can be authenticated and checked during startup, integration, and secure data exchange. Without that identity layer, operators are relying on network location or vendor assumption instead of proof that the device is the expected one. In IoMT, that becomes a safety issue as much as a security issue.
Practical implication: enforce certificate-backed device authentication as part of device onboarding and integration.
Why certificate lifecycle matters more than static perimeter security
IoMT devices operate across manufacturing, hospital deployment, and in some cases patient homes, so trust must survive intermittent connectivity, updates, and eventual replacement. Certificate lifecycle management covers enrollment, renewal, revocation, and replacement when device state changes or a device is compromised. That lifecycle becomes central because a device that is trusted at manufacture is not automatically trusted forever. In connected care, expired, stale, or unreconciled credentials can create silent failure modes that perimeter security never sees.
Practical implication: govern device certificates as lifecycle assets with defined renewal and revocation points.
How encryption and integrity protect clinical data in motion
IoMT traffic often carries patient data or device commands over wireless or network links, which means confidentiality and integrity both matter. Encryption protects the content from disclosure, while integrity controls reduce the chance that data or instructions are altered in transit. That distinction matters because a connected device can be technically reachable but still unsafe if its telemetry or dosage instructions can be modified. The article’s core point is that trust in the device must extend to trust in the data path and the receiving system.
Practical implication: require encrypted, integrity-checked communications for all device-to-system exchanges that influence patient care.
Threat narrative
Attacker objective: The attacker aims to manipulate or disrupt connected medical device operations, compromise patient information, or use one device foothold to affect broader healthcare workflows.
- Entry occurs through vulnerable or weakly governed connected medical devices, including legacy or end-of-life devices that lack sufficient patching and security updates.
- Credential or trust abuse follows when an attacker reaches one device or device-linked pathway and uses that foothold to affect other connected systems or patient data flows.
- Impact appears as disrupted clinical operations, compromised patient data, or unsafe device behaviour that can interfere with care delivery.
Breaches seen in the wild
- GitHub code signing certificate theft 2022: A machine account's compromised token cloned GitHub's Desktop and Atom repos, exposing encrypted signing certificates later revoked.
Read and download The State of NHI & AI Agent Breach Report 2026, covering 150+ breaches impacting Non-Human Identities including AI Agents.
NHI Mgmt Group analysis
IoMT security is a device identity problem before it is a network security problem. The article shows that connected medical devices must be trusted as individual actors, not simply treated as endpoints behind a hospital firewall. That shifts the control question to whether the device can be authenticated, monitored, and safely updated across its full life. For practitioners, the governance unit is the device identity and not just the subnet.
Digital trust is the missing governance layer between device manufacturing and clinical operation. A device may be secure at issuance but still become a risk if certificates, updates, and revocation are not managed as the device moves from factory to hospital to patient environment. That is a lifecycle governance issue, not a one-time deployment issue. The implication is that IoMT programmes need policy continuity across manufacturing, onboarding, operations, and retirement.
Connected care exposes a trust continuity gap that conventional perimeter models do not close. IoMT devices can be intermittently connected, integrated with cloud services, and used in high-stakes clinical workflows, which means trust has to persist even when the device is offline or moving between contexts. This is where static security assumptions break down. Practitioners should treat trust continuity as a core design requirement for every connected device class.
Digital certificates are the control point for authenticity, confidentiality, and integrity in IoMT. The article’s emphasis on device authentication and encrypted communications shows that certificates are doing more than identity proofing. They are also carrying the trust signal for safe data exchange and secure interoperation with other systems. The practical conclusion is that certificate governance becomes a clinical safety dependency, not only a security control.
Consolidated IoMT trust management is now a regulatory readiness issue, not just an architecture preference. The article ties device trust to FDA expectations around reasonable assurance, software bills of materials, and regular security updates. That means fragmented device trust practices create compliance friction as well as operational exposure. For practitioners, the control objective is to prove continuous trust management across all device lines.
What this signals
Device identity has become the anchor point for IoMT governance. Teams that still treat connected medical devices as simple network assets will miss the governance work that matters most: authentication, trust continuity, and lifecycle control. The practical shift is toward managing devices as identity-bearing systems whose trust has to be maintained from manufacturing through retirement.
Certificate lifecycle management is now a clinical operational dependency. Intermittent connectivity, mixed device fleets, and long-lived medical deployments make renewal and revocation harder than in ordinary IT environments. That means identity teams, security teams, and biomedical engineering groups need a shared operating model for trust updates and exception handling.
For practitioners
- Establish certificate-backed device identity Require every connected medical device class to present cryptographic identity before it can join clinical systems, exchange telemetry, or accept remote management commands.
- Map device lifecycle ownership end to end Assign clear ownership for enrollment, renewal, revocation, replacement, and retirement so trust does not drift between manufacturing, hospital deployment, and patient use.
- Harden data-in-motion protections Use encrypted and integrity-protected channels for device telemetry, dosage commands, alerts, and integrations with electronic health record systems.
- Plan for intermittent connectivity and offline operation Design certificate and trust workflows that continue to function during factory outages, site connectivity loss, and other periods when devices cannot depend on always-on network access.
- Consolidate trust policy across product lines Standardise device trust governance across multiple form factors and device families so security policy is consistent even when the operational requirements differ.
Key takeaways
- Connected medical devices widen the security problem because their trust relationships extend across manufacturing, deployment, clinical use, and updates.
- The article ties device trust to identity, certificates, encryption, and lifecycle control, showing that IoMT security is not solved by perimeter controls alone.
- Practitioners need a lifecycle governance model for device trust so identity, revocation, and integrity controls stay aligned with patient care operations.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
OWASP Non-Human Identity Top 10 and MITRE ATT&CK address the attack and risk surface, while NIST SP 800-53 Rev 5 and NIST CSF 2.0 set the governance and control requirements practitioners need to meet.
| Framework | Control / Reference | Relevance |
|---|---|---|
| OWASP Non-Human Identity Top 10 | NHI-04 — Insecure Authentication | IoMT devices depend on proof of identity before they exchange clinical data or accept commands. |
| NHI-07 — Long-Lived Secrets | Device certificates and trust materials become risky when they persist beyond their intended lifecycle. | |
| Recommendation — Use certificate-backed authentication to verify every connected medical device before it enters clinical workflows. Shorten credential lifetimes and enforce renewal and revocation for every device trust asset. | ||
| NIST SP 800-53 Rev 5 | IA-5 — Authenticator Management | IoMT certificate issuance, renewal, and revocation map directly to authenticator lifecycle control. |
| Recommendation — Apply authenticator management controls to device certificates and revoke stale trust immediately. | ||
| NIST CSF 2.0 | PR.AA-05 — Access Permissions, Entitlements and Authorizations | IoMT trust determines which devices and systems are authorised to connect and exchange data. |
| Recommendation — Define and review device authorisations so only trusted IoMT assets can access patient workflows. | ||
| MITRE ATT&CK | TA0006;TA0008 — Credential Access; Lateral Movement | The article highlights how a foothold in one device can spread across connected medical systems. |
| Recommendation — Map device trust failures to credential access and lateral movement paths in healthcare environments. | ||
Key terms
- Internet of Medical Things: Internet of Medical Things, or IoMT, refers to connected medical devices that exchange data with hospital systems, cloud services, or patient monitoring platforms. These devices create both clinical value and security risk because they depend on identity, connectivity, and lifecycle control to operate safely over time.
- Digital Trust: Digital trust is the set of cryptographic and identity controls that allow systems, users, and services to verify each other reliably. It includes PKI, federation, certificates, and authentication foundations that must remain adaptable as technologies and threat conditions change.
- Certificate Lifecycle Management: The governance of digital certificates from issuance through renewal and revocation, ensuring certificates are valid, monitored, and rotated before expiry. Expired certificates are a leading cause of outages and unplanned security gaps.
- Device Identity: Device identity is the cryptographic proof that a specific machine is the thing being accessed, independent of its IP address or current network. In fleet governance, it allows policy, audit, and revocation to follow the device across locations and transports.
Deepen your knowledge
NHI governance, agentic AI identity, and machine identity lifecycle are core topics in our NHI Foundation Level course, the industry's only accredited NHI security programme. If you are building or maturing an IAM or device identity programme, it is worth exploring.
Published by the NHIMG editorial team on June 25, 2026.
Updated on October 8, 2026.
NHI Mgmt Group, the independent authority on Non-Human Identity, IAM, and Agentic AI security. nhimg.org